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Abstract: The following presentation shall be written regarding research performed with Dr. 
Korn in his collaboration with Dr. Bauer of Liberty University’s College of Osteopathic 
Medicine (LUCOM). The focus of the research is that of polymeric nanoparticles, 
specifically a EudragitTM based copolymer in the formation of a capsule for pharmaceutical 
payloads. Nanoparticles are particles that possess a dimension that is less than 100nm. They 
are being explored for new methods of controlled release systems for treatment to deliver 
both soluble and insoluble compounds for medicinal purpose. This research will explore the 
properties of nanoparticles constructed from EudragitTM, a copolymer derived of methacrylic 
and acrylic esters. One specific goal of the research will be to incorporate an enzyme, such 
as alkaline phosphatase, with the nanoparticle. Upon incorporation of the alkaline 
phosphatase or a similar biomolecule, experiments will be performed to measure the activity 
of the enzyme or biomolecule.  The EudragitTM based compound in particular is being 
applied as a pharmaceutical delivery system that is pH-selective; it will maintain structure in 
acidic environments, but releases the contents in more basic environments. Applied to the 
human body, these polymer payloads are designed to carry medication through the acidic 
environment of the stomach to the higher pH found within the more basic environment of the 
intestines and colonic regions of the body. This research is significant both chemically and 
medicinally. Methods of construction of polymeric nanoparticles that generate a microscopic 
powder will be researched to increase understanding of the process of generating and 
refining polymer capsules. This research may also provide insight in assessing the 
EudragitTM nanoparticles’ chemical properties, providing for potential advancement in the 
relatively new field of polymeric nanoparticles. Medicinally, the significance is based in 
advancing the treatment and care of patients. If certain enzymes, proteins, and medicative 
variants may be encapsulated by EudragitTM, treatment options for a variety of illnesses 
could increase. Furthermore, treatment may be more effective if implemented into a 
polymer, making current treatments or medications more efficacious. The ability to enhance 
and create targeted drug delivery systems will expand care and treatment options provided 
by physicians to their patients.  
 
